ЦИКЛОФИЛИН А: СТРОЕНИЕ И ФУНКЦИИ

Обложка

Цитировать

Полный текст

Об авторах

А. А. Калинина

ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России

Автор, ответственный за переписку.
Email: aakalinina89@gmail.com

Анастасия Андреевна Калинина.

115478 Москва, Каширское шоссе, 24

Россия

Л. М. Хромых

ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России

Email: fake@neicon.ru

115478 Москва, Каширское шоссе, 24

Россия

Д. Б. Казанский

ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России

Email: fake@neicon.ru

115478 Москва, Каширское шоссе, 24

Россия

Список литературы

  1. Handschumacher R.E., Harding M.W., Rice J. et. al. Cyclophilin: a specific cytosolic binding protein for cyclosporine A. Science 1984;226(4674):544–6.
  2. Fischer G., Bang H., Mech C. Detection of enzyme catalysis for cis-trans isomerization of peptide bonds using proline containing peptides as substrates. Biomed Biochim Acta 1984;43:1101–12.
  3. Fischer G., Wittmann-Liebold B., Lang K. et al. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989;337(6206):476–8.
  4. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-truns isomerase is the cyclosporin A-binding protein cyclophilin. Nаture 1989;337(6206):473–5.
  5. Wang P., Heitman J. Cyclophilins. Genome Biology 2005;6(7):226.
  6. Honga F., Leeb J., Piaoa Y.J. et al. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity. Biochem Biophys Res Commun 2004;316(4):1073–80.
  7. Song F., Zhang X., Ren X.B. et al Cyclophilin A (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147. J Biol Chem 2011;286(10):8197–203.
  8. Bahmed K., Henry C., Holliday M. et al. Extracellular cyclophilin A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B. Cancer Cell Int 2012;12(1):19.
  9. Zhao Y., Chen Y., Schutkowski M. et al. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 1997;5(1):139–46.
  10. Ryffel B., Woerly G., Greiner B. et al. Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology 1991;72(3):399–404.
  11. Doyle V., Virji S., Crompton M. Evidence that cyclophilin A protects cells against oxidative stress. Biochem J 1999;341 (Pt 1):127–32.
  12. Seko Y., Fujimura T., Taka H. et al. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun 2004;317(1):162–8.
  13. Jäschke A., Mi H., Tropschug M. Human T cell cyclophilin18 binds to thiol-specific antioxidant protein Aop1 and stimulates its activity. J Mol Biol 1998;277(4):763–9.
  14. Hu B.R., Martone M.E., Jones Y.Z., Liu C.L. Protein aggregation after transient cerebral ischemia. J Neurosci 2000;20(9):3191–9.
  15. Colgan J., Asmal M., Neagu M. et al. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 2004;21(2):189–201.
  16. Sherry B., Yarlett N., Strupp A., Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA 1992;89(8):3511–5.
  17. Obchoei S., Wongkhan S., Wongkham C. et al. Cyclophilin A. potential functions and therapeutic target for human cancer. Med Sci Monit 2009;15(11):221–32.
  18. Suzuki J., Jin Z.G., Meoli D.F. et al. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res 2006;98(6):811–7.
  19. Khromykh L.M., Kulikova N.L., Anfalova T.V. et al. Cyclophilin A produced by thymocytes regulates the migration of murine bone marrow cells. Cell Immunol 2007;249(1):46–53.
  20. Bharadwaj U., Zhang R., Yang H. et al. Effects of cyclophilin A on myeloblastic cell line KG-1 derived dendritic like cells (DLC) through p38 MAP kinase activation. J Surg Res 2005;127(1):29–38.
  21. Xu Q., Leiva M.C., Fischkoff S.A. et al. Leukocyte chemotactic activity of cyclophilin. J Biol Chem 1992;267(17):11968–71.
  22. Damsker J.M., Bukrinsky M.I., Constan S.L. Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J Leukoc Biol 2007;82(3):613–8.
  23. Gwinn W.M., Damsker J.M., Falahati R. et al. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J Immunol 2006;177(7):4870–9.
  24. Arora K., Gwinn W.M., Bower M.A. et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 2005;175(1): 517–22.
  25. Nabeshima K., Iwasaki H., Koga K. et al. EMMPRIN (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006;56(7): 359–67.
  26. Yurchenko V., Constant S., Bukrinsky M. Dealing with the family: CD147 interactions with cyclophilins. Immunology 2006;117(3):301–9.
  27. Coste I., Gauchat J.F., Wilson A. et al. Unavailability of CD147 leads to selective erythrocyte trapping in the spleen. Blood 2001;97(12):3984–8.
  28. Konttinen Y.T., Li T.F., Mandelin J. et al. Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum 2000;43(2):275–80.
  29. Damsker J.M., Okwumabua I., Bukrinsky M.I., Constant S.L. Contribution of cyclophilin-CD147 interactions in rheumatoid arthritis. J Immunol 2006;176:47.
  30. Nigro P., Pompilio G., Capogrossi M.C. Cyclophilin A: a key player for human disease. Cell Death Dis 2013;4:e888.
  31. Iacono K.T., Brown A.L., Greene M.I., Saouaf S.J. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 2007;83(3):283–95.
  32. Yang H., Chen J., Yang J. et al. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. Biochem Biophys Res Commun 2007;361(3):763–7.
  33. Li M., Zhai Q., Bharadwaj U. et al. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 2006;106(10):2284–94.
  34. Semba S., Huebner K. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol Cancer Res 2006;4(8):529–38.
  35. Li Z., Zhao X., Bai S. et al. Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics 2008;7(10):1810–23.
  36. Schlegel A.J., Redzic J.S., Porter C.C. et al. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A. J Mol Biol 2009;391(3):518–35.
  37. Gabison E.E., Hoang-Xuan T., Mauviel A., Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005;87(3–4):361–8.
  38. Davies B., Miles D.W., Happerfield L.C. et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67(5):1126–31.
  39. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2(3):161–74.
  40. Tang Y., Nakada M.T., Kesavan P. et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005;65(8):3193–9.
  41. Choi K.J., Piao Y.J., Lim M.J. et al. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxiaand cisplatin-induced cell death. Cancer Res 2007;67(8):3654–62.
  42. Chen S., Zhang M., Ma H. et al. Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance. Cancer Chemother Pharmacol 2008;61(3):459–69.
  43. Grigoryeva E.S., Cherdyntseva N.V., Karbyshev M.S. et al. Expression of cyclophilin A in gastric adenocarcinoma patients and its inverse association with local relapses and distant metastasis. Pathol Oncol Res 2014;20(2):467–73.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ,


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 57560 от  08.04.2014.